Phase II AIDS Malignancy Consortium (AMC) trial of topical halofuginone in AIDS-associated Kaposi’s sarcoma (KS): clinical and biological effects using a novel intra-patient control design

Spremljeno u:
Bibliografski detalji
Glavni autori: Krown, Susan E, Fingleton, Barbara, Lee, Jeannette Y, Egorin, Merrill J, Koon, Henry B
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2010
Teme:
Meeting Abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3002724/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-9378-5-S1-A62
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items